Ifosfamide in the treatment of ovarian cancer

Anna Obrębowska; Stefan Sajdak

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/1999
vol. 3

Send email

Copy url:

abstract:

Ifosfamide in the treatment of ovarian cancer

Anna Obrębowska

,

Stefan Sajdak

Współcz Onkol (1999) 3, 126-128

Online publish date: 2003/08/05

View full text Get citation

Ifosfamide is an antineoplastic drug, which is used in chemotherapy of gynecological cancers. Special place has ifosfamide in the treatment of ovarian cancer, both in singleagent therapy and in combination with cis-platin. More recently, trias have been conducted to study the use of ifosfamide in high-dose chemotherapy with autologous bone marrow transplantation.

In thsi article results of chemotherapy with ifosfamide as a second line treatment in advanced ovarian cancer are presented.

keywords:

Ifosfamide in the treatment of ovarian cancer

Anna Obrębowska , Stefan Sajdak

ovarian cancer, ifosfamide, chemotherapy

Anna Obrębowska

,

Stefan Sajdak